American Vanguard Corp
NYSE:AVD
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.36
6.27
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
American Vanguard Corp
American Vanguard Corp. is a holding company, which engages in the development and marketing of specialty and agricultural products for crop protection and management, turf and ornamentals management, and public and animal health. The company is headquartered in Newport Beach, California and currently employs 804 full-time employees. The firm is primarily a specialty chemical manufacturer that develops and markets products for agricultural, commercial and consumer uses. The firm manufactures and formulates chemicals for crops, human and animal protection. AVD conducts its business through, its principle operating subsidiaries, including AMVAC Chemical Corporation (AMVAC) for its domestic business and AMVAC Netherlands BV (AMVAC BV) for its international business. AMVAC is a manufacturer of chemical, biological and biorational products that develops and markets solutions for agricultural, commercial and consumer uses. The Company’s products include insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, and soil fumigants, are marketed in liquid, powder, and granular forms. AMVAC BV sells product both directly and through its network of subsidiaries in various international territories.
American Vanguard Corp. is a holding company, which engages in the development and marketing of specialty and agricultural products for crop protection and management, turf and ornamentals management, and public and animal health. The company is headquartered in Newport Beach, California and currently employs 804 full-time employees. The firm is primarily a specialty chemical manufacturer that develops and markets products for agricultural, commercial and consumer uses. The firm manufactures and formulates chemicals for crops, human and animal protection. AVD conducts its business through, its principle operating subsidiaries, including AMVAC Chemical Corporation (AMVAC) for its domestic business and AMVAC Netherlands BV (AMVAC BV) for its international business. AMVAC is a manufacturer of chemical, biological and biorational products that develops and markets solutions for agricultural, commercial and consumer uses. The Company’s products include insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, and soil fumigants, are marketed in liquid, powder, and granular forms. AMVAC BV sells product both directly and through its network of subsidiaries in various international territories.
EBITDA Surge: Adjusted EBITDA jumped from $1.8 million to $8.2 million year-over-year, a rise of more than 350%, with management expecting a strong Q4 finish.
Margin Expansion: Gross profit margin improved by 300 basis points year-over-year, reaching 29% as operational and manufacturing efficiencies took hold.
Expense Cuts: Operating expenses dropped by $6 million versus Q3 2024 and by $14 million year-to-date, reflecting broad cost discipline that management says is now part of company culture.
Guidance Update: Full-year adjusted EBITDA guidance was reiterated at $40–44 million, while net sales guidance was lowered to $520–535 million due to weaker international markets.
Inventory & Cash Flow: Inventory was reduced by $47 million and net trade working capital by $24 million year-over-year, supporting improved cash flow and ongoing debt paydown.
Specialty Business Rebound: Specialty (formerly non-crop) business was impacted by a product liability issue but is expected to return to growth in Q4 and beyond as claims are processed.
Growth Pipeline: Management highlighted a medium-term growth portfolio targeting $100 million in net sales, with new product launches expected to ramp from 2028 onward.
